Latest news

19/06/2024

Project start for translational, cross-DZG research project in Dresden

United against common diseases! This is the mission of the German Centers for Health Research (DZG). Their scientists are working to optimize the translation of research results into patient care,…

11/06/2024

DKTK Munich: Phagocytes from the culture dish for cancer therapy

Cell-based cancer therapies often fail nowadaystoday because the immune cells are unable to penetrate the tumor efficiently. The use of certain phagocytes is considered a promising alternative - but…

08/05/2024

Newly discovered mechanism of T-cell control can interfere with cancer immunotherapies

Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another cell type of the immune system. In this way, the body presumably curbs…

26/04/2024

Tumor cells evade the immune system early on

Tumors actively prevent the formation of immune responses by so-called cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the…

17/04/2024

ERC Advanced Grant for Michael Platten

The European Research Council (ERC) supports visionary, ground-breaking research projects with its Advanced Grant. This year, the Council awarded the prestigious funding to the Neurologist Michael…

12/04/2024

Ashish Goyal, Jens Bauer, Joschka Hey: Waltraud Lewenz Prize

This year's winners of the Waltraud Lewenz Prize are a team of young scientists: Senior Postdoc Dr. Ashish Goyal (Heidelberg) together with his co-first authors PhD student Jens Bauer (Tübingen) and…

10/04/2024

DKTK School of Oncology Tech Talk : “Advancing liquid biopsies for monitoring and personalized tumor patient treatment”

In the DKTK School of Oncology's first Tech Talk of 2024 on March 12, Dr. Christof Winter and PD Hedwig Deubzer discussed the benefits of Liquid Biopsies in pediatric and adult cancers.

10/04/2024

First DZG Heidelberg-Mannheim Day brings together 150 representatives from six DZG

150 representatives from six German Centers for Health Research (DZG) from the partner sites in Heidelberg and Mannheim met on February, 28 2024 for the first DZG Heidelberg-Mannheim Day. Overview…

05/04/2024

Cancer, Diabetes, & Neurodegenerative Diseases – The 6th Joint Dresden DZG Symposium brings together a variety of Dresden researchers once again.

The 6th Joint Dresden DZG Symposium took place on March 26, 2024: The three German Centers for Health Research (DZG) located in Dresden play a significant role on Dresden's biomedical campus, with 250…

03/04/2024

DZG Innovation Fund: Promoting Cross-Disease Research enters in the thrid round

The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research. For each round of calls for proposals, there will be an agreed research topic that allows…

15/03/2024

Machine learning classifier accelerates the development of cellular immunotherapies

Making a personalised T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ), the University Medical Center Mannheim and the…

02/02/2024

The gut microbiome prevents dangerous immune reactions

After stem cell transplantation, the donated immune cells sometimes attack the patients' bodies. This is known as graft versus host disease or GvHD. Researchers at the Technical University of Munich…

12/01/2024

Prostate cancer: Newly-developed inhibitor shows massive potential

New epigenetic inhibitor is also effective in treatment-resistant prostate cancer cells

18/12/2023

Lively exchange: DKFZ/NCT/DKTK HARPOON Workshop

The fourth DKFZ/NCT/DKTK HARPOON workshop took place in Heidelberg on November 23 and 24 with lively participation of well over 100 experts in attendance. HARPOON stands for HArmonisation of Reporting…

22/11/2023

Pediatric oncology: Scientists discover new Achilles heel of leukemia cells

Leukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific mode of action. A team from the Department of…

27/10/2023

Epigenetically acting drugs could support cancer immunotherapy

Epigenetically active drugs enable the cell to read parts of the genome that were previously blocked and inaccessible. This leads to the formation of new mRNA transcripts and also new proteins, as…

29/09/2023

Transgenic T cells against malignant brain tumors

Scientists from the German Cancer Research Center (DKFZ), the University Medical Center Mannheim (UMM) and the German Cancer Consortium (DKTK) successfully tested a new form of cellular immunotherapy…

08/09/2023

10th Munich Cancer Retreat

At the already 10th Munich Cancer Retreat (MCR10), the Key Note Lectures were given by two new members of the DKTK Scientific Advisory Board (SAB). Stefanie Polat (Siemens Healthineers, Erlangen)…

06/09/2023

Two ERC Starting Grants to DKFZ Young Scientists

The funding provided by the European Research Council (ERC) is regarded as an accolade for scientists at all career stages. With its "Starting Grants", the ERC aims to pave the way for excellent young…

26/07/2023

DKTK Retreat Heidelberg 2023

On July 14, 2023, "INFORM – NETWORK – EXCHANGE" was the motto for DKTK Heidelberg scientists when they gathered for their joint local retreat 2023. In addition to overview presentations on the 5 major…